Washington Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$211K Buy
+1,000
New +$201K 0.01% 281
2025
Q2
– Sell
-400
Closed -$51.2K – 461
2025
Q1
$51.2K Sell
400
-116
-22% -$15.7K ﹤0.01% 403
2024
Q4
$68.2K Hold
516
– – ﹤0.01% 396
2024
Q3
$75.1K Sell
516
-40
-7% -$5.79K ﹤0.01% 388
2024
Q2
$76.3K Hold
556
– – ﹤0.01% 385
2024
Q1
$76.3K Sell
556
-40
-7% -$5.46K ﹤0.01% 393
2023
Q4
$81K Buy
596
+405
+212% +$49.4K ﹤0.01% 360
2023
Q3
$23.4K Hold
191
– – ﹤0.01% 516
2023
Q2
$24.2K Sell
191
-180
-49% -$23.4K ﹤0.01% 539
2023
Q1
$47.9K Hold
371
– – ﹤0.01% 421
2022
Q4
$48.7K Hold
371
– – ﹤0.01% 405
2022
Q3
$43K Hold
371
– – ﹤0.01% 415
2022
Q2
$44K Hold
371
– – ﹤0.01% 425
2022
Q1
$48K Hold
371
– – ﹤0.01% 440
2021
Q4
$57K Hold
371
– – ﹤0.01% 417
2021
Q3
$60K Buy
371
+75
+25% +$12.6K ﹤0.01% 493
2021
Q2
$48K Sell
296
-140
-32% -$21.6K ﹤0.01% 529
2021
Q1
$66K Buy
436
+71
+19% +$11.3K ﹤0.01% 452
2020
Q4
$55K Hold
365
– – ﹤0.01% 473
2020
Q3
$49K Buy
365
+140
+62% +$19K ﹤0.01% 449
2020
Q2
$30K Sell
225
-138
-38% -$17.6K ﹤0.01% 482
2020
Q1
$39K Buy
+363
New +$41.8K ﹤0.01% 428
2018
Q3
– Sell
-225
Closed -$25K – 497
2018
Q2
$25K Buy
+225
New +$24.1K ﹤0.01% 527

Other funds holding IBB

Washington Trust's IBB Position: Q3 2026 in Review

Washington Trust opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 1,000 shares worth $211K. The stake represents 0.01% of the portfolio and ranks #281 among its holdings. This is a return to the name: Washington Trust previously reported a position in IBB as recently as Q1 2025.

Washington Trust first reported a position in IBB in Q2 2018 and has held it in 23 quarters since. 795 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Washington Trust held 1,000 shares of iShares Biotechnology ETF worth $211K as of Q3 2026.
  • iShares Biotechnology ETF was a new Washington Trust position in Q3 2026.
  • iShares Biotechnology ETF made up 0.01% of Washington Trust's portfolio in Q3 2026, its #281 holding.
  • Washington Trust first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 23 quarters since.
  • 795 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Washington Trust's 13F filing for Q3 2026, filed 22 Oct 2026.